Alligator Bioscience AB (LTS:0RK9) Accounts Payable : kr7.82 Mil (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Alligator Bioscience AB Accounts Payable?

Alligator Bioscience AB's Accounts Payable for the quarter that ended in Mar. 2025 was kr7.82 Mil.

Alligator Bioscience AB's quarterly Accounts Payable declined from Sep. 2024 (kr6.85 Mil) to Dec. 2024 (kr3.95 Mil) but then increased from Dec. 2024 (kr3.95 Mil) to Mar. 2025 (kr7.82 Mil).

Alligator Bioscience AB's annual Accounts Payable increased from Dec. 2022 (kr13.34 Mil) to Dec. 2023 (kr21.27 Mil) but then declined from Dec. 2023 (kr21.27 Mil) to Dec. 2024 (kr3.95 Mil).

Alligator Bioscience AB Accounts Payable Historical Data

The historical data trend for Alligator Bioscience AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alligator Bioscience AB Accounts Payable Chart

Alligator Bioscience AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable

Get a 7-Day Free Trial

6.54

9.37

13.34

21.27

3.95

Alligator Bioscience AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable	Get a 7-Day Free Trial															5.45	10.70	6.85	3.95	7.82

Alligator Bioscience AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Alligator Bioscience AB Accounts Payable Related Terms

Thank you for viewing the detailed overview of Alligator Bioscience AB's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Alligator Bioscience AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (LTS:0RK9) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

ATORX:Sweden 7AL0:Germany

Address

Medicon Village, Scheeletorget 1, Lund, SWE, 223 81

Website

https://www.alligatorbioscience.se

Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. Its drug candidate mitazalimab, is currently in preparation for Phase 3 development, and has previously presented unprecedented survival data at 18-months follow up in first-line metastatic pancreatic cancer patients in the Phase 2 trial OPTIMIZE-1.

Alligator Bioscience AB Headlines

No Headlines